Company Filing History:
9 out of 266 
1 out of 5,069 
Years Active: 2014-2020
Title: El Bachir Kaloun: Innovator in Cancer Treatment
Introduction
El Bachir Kaloun is a prominent inventor based in Roquettes, France, known for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has focused on developing innovative compounds aimed at treating cancer.
Latest Patents
Among his latest patents, Kaloun has developed Hemi-synthetic trilobine analogs for use as a drug. This invention concerns a compound that serves as a DNMT inhibitor, particularly in the treatment of cancer. Another notable patent involves Flavagline derivatives, which are compounds designed for use as medicaments, specifically targeting cancer treatment. These inventions highlight his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Kaloun has worked with esteemed organizations such as Pierre Fabre Medicament and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Throughout his career, Kaloun has collaborated with talented individuals, including Karim Bedjeguelal and Rémi Rabot. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
El Bachir Kaloun's work in developing novel compounds for cancer treatment underscores his role as a key innovator in the pharmaceutical field. His contributions continue to pave the way for advancements in medical therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.